P3.01-036 A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: An Interim Analysis
2017 ◽
Vol 12
(11)
◽
pp. S2214
◽
Y. Wu
◽
H. Tu
◽
J. Feng
◽
M. Shi
◽
J. Zhao
◽
...
2019 ◽
Vol 30
◽
pp. ix161-ix162
F. De Marinis
◽
K.K. Laktionov
◽
A. Poltoratskiy
◽
I. Egorova
◽
M. Hochmair
◽
...
2019 ◽
Vol 14
(10)
◽
pp. S853-S854
F. De Marinis
◽
K.K. Laktionov
◽
A. Poltoratskiy
◽
I. Egorova
◽
M.J. Hochmair
◽
...
2019 ◽
Vol 30
◽
pp. v598-v599
F. de Marinis
◽
K.K. Laktionov
◽
A. Poltoratskiy
◽
I. Egorova
◽
M. Hochmair
◽
...
2018 ◽
Vol 36
(15_suppl)
◽
pp. 1051-1051
Peter A. Fasching
◽
Arnd Nusch
◽
Bernhard Heinrich
◽
Sara Brucker
◽
Thomas Decker
◽
...
2019 ◽
Vol 14
(10)
◽
pp. S1050-S1051
J. Wang
◽
J. Zhao
◽
H. Bai
◽
X. Wang
◽
Y. Wang
◽
...
2018 ◽
Vol 29
◽
pp. ix158
Q. Zhou
◽
H. Zhang
◽
L. Jiang
◽
Y. Shi
◽
Y. Chen
◽
...
2019 ◽
Vol 30
◽
pp. ii48-ii49
◽
A. Passaro
◽
K.K. Laktionov
◽
A. Poltoratskiy
◽
I. Egorova
◽
M. Hochmair
◽
...
2019 ◽
Vol 14
(10)
◽
pp. S679-S680
◽
Y. Wu
◽
H. Tu
◽
J. Feng
◽
M. Shi
◽
J. Zhao
◽
...
Hai-Yan Tu
◽
Jifeng Feng
◽
Meiqi Shi
◽
Jun Zhao
◽
Yuyan Wang
◽
...
2019 ◽
Vol 30
◽
pp. ix153-ix154
J. Wang
◽
J. Zhao
◽
H. Bai
◽
X. Wang
◽
Y. Wang
◽
...